-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Biomarin Pharmaceutical Inc annual Deferred State and Local Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Biomarin Pharmaceutical Inc annual Deferred State and Local Income Tax Expense (Benefit) for 2023 was -$8.03 M, a 56.1% decline from 2022.
- Biomarin Pharmaceutical Inc annual Deferred State and Local Income Tax Expense (Benefit) for 2022 was -$5.14 M, a 318% decline from 2021.
- Biomarin Pharmaceutical Inc annual Deferred State and Local Income Tax Expense (Benefit) for 2021 was -$1.23 M, a 76.9% increase from 2020.
Deferred State and Local Income Tax Expense (Benefit), Annual Data (USD)